PharVision Advisers »

Alexander & Baldwin shares owned by PharVision Advisers

Quarter-by-quarter ownership of Alexander & Baldwin (ALEX) shares owned by PharVision Advisers from 13F filings

Historical chart of PharVision Advisers investment in Alexander & Baldwin

Tip: Access up to 7 years of quarterly data

All positions including Alexander & Baldwin held by PharVision Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alexander & Baldwin by PharVision Advisers

Quarter filed Position value Share count Share price at filing
2025-03-31 $231k 13k 17.23
2024-12-31 $209k 12k 17.74

More positions owned by PharVision Advisers

Wayfair Cl A (W)
ExlService Holdings (EXLS)
Up Fintech Hldg Sponsored Ads (TIGR)
Array Technologies Com Shs (ARRY)
Sprouts Fmrs Mkt (SFM)
Corporacion Amer Arpts S A (CAAP)
Vertiv Holdings Com Cl A (VRT)
Zevra Therapeutics Com New (ZVRA)
Bowhead Specialty Hldgs Com Shs (BOW)
Lexinfintech Hldgs Adr (LX)
Euronet Worldwide (EEFT)
Rigel Pharmaceuticals (RIGL)
Masimo Corporation (MASI)
LSB Industries (LXU)
Bright Horizons Fam Sol In D (BFAM)

View all positions for PharVision Advisers

Top funds holding Alexander & Baldwin

BlackRock
Vanguard Group
State Street Corporation
Franklin Resources
Charles Schwab Investment Management
Geode Capital Management
Jpmorgan Chase & Co
Nuveen
Northern Trust
London Company
Qube Research & Technologies
Dimensional Fund Advisors
Bank of New York Mellon
Allianz Asset Management
Goldman Sachs Group

View all funds holding Alexander & Baldwin